{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T17:29:32Z","timestamp":1786728572945,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/jcrt.jcrt_1049_17","type":"journal-article","created":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:37:29Z","timestamp":1529915849000},"page":"896-901","source":"Crossref","is-referenced-by-count":5,"title":["Using 18 F-fluorodeoxyglucose positron emission tomography\/computed tomography to estimate the length of gross tumor and involvement of lymph nodes in esophagogastric junction carcinoma"],"prefix":"10.4103","volume":"14","author":[{"given":"Chi-Luan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Rong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Bo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Ping","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-30-20230619","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.gie.2011.01.030","article-title":"EUS for the staging of gastric cancer: A meta-analysis","volume":"73","author":"Mocellin","year":"2011","journal-title":"Gastrointest Endosc"},{"key":"R2-30-20230619","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1097\/RLU.0000000000000661","article-title":"Is there a role for PET\/CT with esophagogastric junction adenocarcinoma","volume":"40","author":"Fuster","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R3-30-20230619","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.ijsu.2007.05.009","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography in the preoperative staging of thoracic oesophageal and gastro-oesophageal junction cancer: A prospective study","volume":"5","author":"Katsoulis","year":"2007","journal-title":"Int J Surg"},{"key":"R4-30-20230619","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.acra.2008.06.004","article-title":"Prediction of metastatic disease and survival in patients with gastric and gastroesophageal junction tumors: The incremental value of PET-CT over PET and the clinical role of primary tumor volume measurements","volume":"16","author":"Roedl","year":"2009","journal-title":"Acad Radiol"},{"key":"R5-30-20230619","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1200\/JCO.2004.01.083","article-title":"Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer","volume":"22","author":"van Westreenen","year":"2004","journal-title":"J Clin Oncol"},{"key":"R6-30-20230619","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1200\/JCO.2000.18.18.3202","article-title":"Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma","volume":"18","author":"Flamen","year":"2000","journal-title":"J Clin Oncol"},{"key":"R7-30-20230619","first-page":"1808","article-title":"18F-FDG PET definition of gross tumor volume for radiotherapy of non-small cell lung cancer: Is a single standardized uptake value threshold approach appropriate","volume":"47","author":"Biehl","year":"2006","journal-title":"J Nucl Med"},{"key":"R8-30-20230619","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.ijrobp.2009.07.1681","article-title":"Comparison of (18) F-fluorothymidine and (18) F-fluorodeoxyglucose PET\/CT in delineating gross tumor volume by optimal threshold in patients with squamous cell carcinoma of thoracic esophagus","volume":"76","author":"Han","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-30-20230619","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.7314\/APJCP.2014.15.24.10899","article-title":"Role of PET\/CT in treatment planning for head and neck cancer patients undergoing definitive radiotherapy","volume":"15","author":"Arslan","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R10-30-20230619","first-page":"75","article-title":"Aprospective study comparing functional imaging (18 F-FDG PET) versus anatomical imaging (Contrast enhanced CT) in dosimetric planning for non-small cell lung cancer","volume":"5","author":"Prathipati","year":"2017","journal-title":"Asia Ocean J Nucl Med Biol"},{"key":"R12-30-20230619","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4103\/0973-1482.163679","article-title":"Improving the accuracy of target volume delineation by combined use of computed tomography, magnetic resonance imaging and positron emission tomography in head and neck carcinomas","volume":"11","author":"Chauhan","year":"2015","journal-title":"J Cancer Res Ther"},{"key":"R13-30-20230619","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4103\/0973-1482.131445","article-title":"PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer","volume":"10","author":"Tural","year":"2014","journal-title":"J Cancer Res Ther"},{"key":"R14-30-20230619","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.clon.2008.06.004","article-title":"Improving observer variability in target delineation for gastro-oesophageal cancer \u2013 The role of (18F) fluoro-2-deoxy-D-glucose positron emission tomography\/computed tomography","volume":"20","author":"Vesprini","year":"2008","journal-title":"Clin Oncol (R Coll Radiol"},{"key":"R15-30-20230619","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ijrobp.2003.10.044","article-title":"Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer","volume":"59","author":"Bradley","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-30-20230619","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijrobp.2008.04.015","article-title":"Using 18F-fluorodeoxyglucose positron emission tomography to estimate the length of gross tumor in patients with squamous cell carcinoma of the esophagus","volume":"73","author":"Zhong","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R17-30-20230619","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0169-5002(97)00086-X","article-title":"The contribution of 18F-fluoro-2-deoxy-glucose positron emission tomographic imaging to radiotherapy planning in lung cancer","volume":"19","author":"Kiffer","year":"1998","journal-title":"Lung Cancer"},{"key":"R18-30-20230619","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2006.02.014","article-title":"Aprospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancer","volume":"78","author":"Leong","year":"2006","journal-title":"Radiother Oncol"},{"key":"R19-30-20230619","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.7150\/jca.21582","article-title":"Advantage of PET\/CT in target delineation of MRI-negative cervical lymph nodes in intensity-modulated radiation therapy planning for nasopharyngeal carcinoma","volume":"8","author":"Shen","year":"2017","journal-title":"J Cancer"},{"key":"R22-30-20230619","doi-asserted-by":"crossref","first-page":"619","DOI":"10.4103\/0973-1482.106580","article-title":"Positron emission tomography\/computed tomography and esophageal cancer in the clinical practice: How does it affect the prognosis","volume":"8","author":"Cervino","year":"2012","journal-title":"J Cancer Res Ther"},{"key":"R23-30-20230619","doi-asserted-by":"crossref","first-page":"e759","DOI":"10.1016\/j.ijrobp.2010.10.065","article-title":"Aprospective evaluation of staging and target volume definition of lymph nodes by 18FDG PET\/CT in patients with squamous cell carcinoma of thoracic esophagus","volume":"81","author":"Yu","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R24-30-20230619","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1200\/JCO.1998.16.6.2142","article-title":"Lymph node staging in non-small-cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients","volume":"16","author":"Vansteenkiste","year":"1998","journal-title":"J Clin Oncol"},{"key":"R25-30-20230619","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2967\/jnumed.107.044362","article-title":"18F-FDG PET for mediastinal staging of lung cancer: Which SUV threshold makes sense","volume":"48","author":"Hellwig","year":"2007","journal-title":"J Nucl Med"},{"key":"R26-30-20230619","doi-asserted-by":"crossref","first-page":"e78552","DOI":"10.1371\/journal.pone.0078552","article-title":"Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of 18 F-FDG PET\/CT","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"R27-30-20230619","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.athoracsur.2005.12.047","article-title":"Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer","volume":"82","author":"Bryant","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"R28-30-20230619","first-page":"1255","article-title":"Additional value of PET\/CT over PET in assessment of locoregional lymph nodes in thoracic esophageal squamous cell cancer","volume":"47","author":"Yuan","year":"2006","journal-title":"J Nucl Med"},{"key":"R29-30-20230619","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2967\/jnumed.106.036509","article-title":"Diagnostic and prognostic value of 18F-FDG PET\/CT for patients with suspected recurrence from squamous cell carcinoma of the esophagus","volume":"48","author":"Guo","year":"2007","journal-title":"J Nucl Med"},{"key":"R30-30-20230619","first-page":"181","article-title":"Failure in presumption of residual disease by quantification of FDG uptake in esophageal squamous cell carcinoma immediately after radiotherapy","volume":"20","author":"Nakamura","year":"2002","journal-title":"Radiat Med"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01363817-201814040-00030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:28:46Z","timestamp":1786724926000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01363817-201814040-00030"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_1049_17","relation":{},"ISSN":["0973-1482"],"issn-type":[{"value":"0973-1482","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}